Female condom joins SA's fight against AIDS

DonateNow
Print this article

Female condom joins SA's fight against AIDS

Sunday Times, South Africa - Sunday, February 14, 1999
Charmain Naidoo, New York


SOUTH Africa has placed an order for 1,5 million female condoms in its fight against AIDS, unwanted pregnancies and the transmission of sexually transmitted diseases. The order is part of the manufacturing company Female Health's multiyear contract with the United Nations Joint Programme on AIDS (UNAIDS). The condoms were market tested in 1997.

Statistics show that women are the fastest growing HIV- positive group in the world. It is expected that by the end of next year women will make up the majority of those newly infected with HIV.

In South Africa, more than 17 percent of the population is infected. In the worst hit province, KwaZulu-Natal, almost one third of pregnant women are infected.

Results from an UNAIDS study in 1997 showed that when the female condom was made available, sexually transmitted diseases fell by 34 percent and the number of unprotected sex acts decreased by 25 percent.

The female condom has not been well accepted in the US, where it was introduced in 1994.

However, since the UNAIDS programme took the condom on as a means of protection for women in developing countries it has negotiated bulk sale discounts, which have seen the retail price fall about 75 percent. Zambia, Uganda, Zimbabwe, Brazil, Venezuela and Tanzania are some of the countries that have put in orders for the female condom.

Studies supported by UNAIDS show that when the female condom is available there is a significant reduction in the incidence of sexually transmitted disease and that it is highly cost-effective.

Dr Mary Anne Leeper, the president and chief operating officer of the Chicago-based Female Health Company, has been negotiating the deal with the South African Department of Health.

She said: "Everyone [in the US] thought we were a gimmick. The media made a joke of it and everyone forgot what it was doing. It's saving lives."

In April last year an UNAIDS meeting in Pretoria was devoted exclusively to the female condom. Eighty delegates from 15 Southern and East African countries called for greater availability and access to it.

At the meeting, Leeper said: "Here you are talking about a need that is just terrible. In Botswana, 20 percent of the sexually active population has AIDS. It's beyond comprehension. They're all dying. The average lifespan was 65; now it's down in the low 40s.

"The ones who are dying are the young people. The life of the country is being squeezed out."

It is widely known that the male condom has had a luke warm response in Africa.

The female condom is a prelubricated disposable sheath made of fine polyurethane, unlike the male condom which is made of latex. It is inserted by the woman into the vaginal canal before intercourse. The flexible ring inside the closed end is used to insert the condom. Like a diaphragm, it hugs the cervix. The outer ring of the sheath is worn outside the body, covering the labia and providing a barrier from the penis. The condom should be used only once.

According to the manufacturer, the female condom will prevent pregnancy in 95 percent of users over the course of a year.
990214
ST990204


Copyright © 1999 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .